[Skip to Content]
[Skip to Content Landing]
Views 731
Citations 0
Comment & Response
October 6, 2015

Treatment of Uncomplicated Acute Appendicitis

Author Affiliations
  • 1Epsom and St Helier University NHS Trust, Surrey, England
JAMA. 2015;314(13):1402-1403. doi:10.1001/jama.2015.11423

To the Editor We believe the results of the APPAC trial1 should be interpreted and used with caution despite it being a randomized trial. First, there is concern over the increasing global problem of antibiotic resistance2; triple therapy, including broad-spectrum carbapenem antibiotics, such as ertapenem, for appendicitis seems like overtreatment. Use of carbapenem antibiotics (once reserved for patients in the intensive care unit setting against multiresistant gram-negative bacteria) have produced resistant Enterobacteriaceace.

First Page Preview View Large
First page PDF preview
First page PDF preview